Form 13-F position report

DOLBY LABORATORIES INC

Reported by Pacer Advisors Inc

DLB CUSIP 25659T107 Manager CIK 0001616667

Reported 7,194 shares, down 509,098 (98.6%) from the prior quarter.

Reported value -98.8%; share count -98.6% vs. the prior quarter.

Reduced
% of reported 13F value < 0.01% This manager · Q2 2026
Shares 7,194 Quarter-end amount reported
Reported value $378,000 Fair value at quarter end
Consecutive quarters held 14 Through Q2 2026

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2023-03-31 119844
2023-06-30 338653
2023-09-30 603961
2023-12-31 1414903
2024-03-31 1324487
2024-06-30 1847644
2024-09-30 1011880
2024-12-31 3219516
2025-03-31 13073424
2025-06-30 16633943
2025-09-30 32124826
2025-12-31 30690931
2026-03-31 31008000
2026-06-30 378000

Quarterly position history

How this manager's reported quarter-end position changed over time.

14 quarters
Quarterly reported position history for DOLBY LABORATORIES INC held by Pacer Advisors Inc.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q2 2026 Reduced 7,194 -509,098 (-98.6%) < 0.01% $378,000 2026-08-13
Q1 2026 Added 516,292 +38,389 (8.0%) 0.09% $31,008,000 2026-05-06
Q4 2025 Added 477,903 +34,006 (7.7%) 0.08% $30,690,931 2026-02-04
Q3 2025 Added 443,897 +219,901 (98.2%) 0.08% $32,124,826 2025-10-15
Q2 2025 Added 223,996 +61,209 (37.6%) 0.04% $16,633,943 2025-08-12
Q1 2025 Added 162,787 +121,564 (294.9%) 0.03% $13,073,424 2025-05-06
Q4 2024 Added 41,223 +28,001 (211.8%) < 0.01% $3,219,516 2025-01-22
Q3 2024 Reduced 13,222 -10,098 (-43.3%) < 0.01% $1,011,880 2024-11-12
Q2 2024 Added 23,320 +7,509 (47.5%) < 0.01% $1,847,644 2024-08-13
Q1 2024 Reduced 15,811 -607 (-3.7%) < 0.01% $1,324,487 2024-05-10
Q4 2023 Added 16,418 +8,798 (115.5%) < 0.01% $1,414,903 2024-01-16
Q3 2023 Added 7,620 +3,573 (88.3%) < 0.01% $603,961 2023-11-13
Q2 2023 Added 4,047 +2,644 (188.5%) < 0.01% $338,653 2023-07-12
Q1 2023 New 1,403 +1,403 (0.0%) < 0.01% $119,844 2023-05-02
Five years are shown. A free account unlocks the complete reported history. Unlock full history

Who else reported the position

469 managers reported DOLBY LABORATORIES INC for Q2 2026.

Managers reporting DOLBY LABORATORIES INC in Q2 2026.
Manager Activity Shares Change % of reported 13F Reported value Tenure
BlackRock Inc Added 6,676,885 +138,549 < 0.01% $351,070,612 8 qtrs
VANGUARD PORTFOLIO MANAGEMENT LLC Reduced 4,950,702 -20,122 0.01% $260,307,911 2 qtrs
THE BANK OF NEW YORK MELLON CORPORATION Added 4,817,216 +317,396 0.04% $253,289,205 53 qtrs
MORGAN STANLEY Reduced 4,601,750 -540,418 0.01% $241,960,122 53 qtrs
VANGUARD CAPITAL MANAGEMENT LLC Reduced 2,721,876 -4,499 < 0.01% $143,116,240 2 qtrs
FIRST TRUST ADVISORS LP Added 2,705,504 +450,571 0.08% $142,255,188 31 qtrs
STATE STREET CORPORATION Added 2,317,402 +26,823 < 0.01% $121,848,997 53 qtrs
ACADIAN ASSET MANAGEMENT LLC Added 1,897,597 +326,223 0.12% $99,742,000 28 qtrs
GEODE CAPITAL MANAGEMENT LLC Added 1,842,203 +77,094 < 0.01% $96,878,235 53 qtrs
FMR LLC Added 1,585,579 +573,059 < 0.01% $83,369,748 35 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
June 30, 2026
Filed
August 13, 2026
Filing type
13F-HR
Position type
Common Stock - Domestic

Voting authority reported

Sole
7,194
Shared
0
None
0

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.